Task: Please answer the following question about the molecule with SMILES CCCCCCCCCCCC(=O)OCCNC(=O)C[n+]1ccccc1.[Cl-].
Question: What is the highest development stage achieved for this compound across all indications? Please respond with Approved, Phase 3 Clinical Trials, Phase 2 Clinical Trials, Phase 1 Clinical Trials, Early Phase 1 Clinical Trials, or Clinical Phase Unknown.
Result: Approved
Task: Please answer the following question about the molecule with {SMILES__description} {SMILES#}.
{#Description|Question|Request!}: {quest#}
{#Result|Answer|Completion!}: {answ#}
CCCCCCCCCCCC(=O)OCCNC(=O)C[n+]1ccccc1.[Cl-]
CCCCCCCCCCCC(=O)OCCNC(=O)C[n+]1ccccc1.[Cl-]
2-[(2-pyridin-1-ium-1-ylacetyl)amino]ethyl dodecanoate;chloride
What is the highest development stage achieved for this compound across all indications? Please respond with Approved, Phase 3 Clinical Trials, Phase 2 Clinical Trials, Phase 1 Clinical Trials, Early Phase 1 Clinical Trials, or Clinical Phase Unknown.